Atrial Natriuretic Peptide (ANP) (1-28), human, porcine

$95.00$165.00

Atrial natriuretic peptide (ANP), a stimulator of particulate guanylate cyclase, has been found to protect against reoxygenation-induced hypercontracture in isolated cardiomyocytes by increasing cyclic guanosine monophosphate synthesis; ANP also contributes to stimulation of lipolysis during repeated bouts of exercise and in the control of lipolysis during exercise.

Clear
Catolog No: N/A Category:

Sequence (One-Letter Code):

SLRRSSCFGGRMDRIGAQSGLGCNSFRY (Disulfide bridge: 7-23)

 

Sequence (Three-Letter Code):

{Ser}{Leu}{Arg}{Arg}{Ser}{Ser}{Cys}{Phe}{Gly}{Gly}{Arg}{Met}{Asp}{Arg}{Ile}{Gly}{Ala}{Gln}{Ser}{Gly}{Leu}{Gly}{Cys}{Asn}{Ser}{Phe}{Arg}{Tyr}

 

Molecular Weight:

3080.5

 

Purity:
% Peak Area By HPLC ≥ 95%

 

Salt:
TFA Salt

 

Storage:

Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months.

 

Note:

This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.

 

Documents:

MSDS

Amount

0.5 mg, 1 mg, Other